Sun Pharma and Sun Pharma Advanced Research Co. (SPARC) have inked a licensing agreement for the commercialization of benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection ...

New Delhi: Sun Pharmaceutical Industries Ltd on Wednesday launched its phenobarbital sodium injection, SEZABY for the treatment of neonatal seizures in the US. It is a benzyl alcohol-free and ...

Sun Pharmaceutical Industries Limited and its wholly-owned subsidiary Sun Pharma Advanced Research Company Ltd. (SPARC), announced the signing of a licensing agreement for commercialization of benzyl ...

Phenobarbital (Barbinol 200) is a barbiturate, prescribed for seizures and as a sedative to relieve anxiety.It works by slowing activity in the brain. The information provided on this page is intended ...

The results of four clinical trials support the safety and efficacy of hypothermia to decrease death and disability in infants with hypoxic-ischemic encephalopathy (HIE) (1–4). However, in these ...

Mumbai (Maharashtra) [India], November 9 (ANI): Mumbai-based Sun Pharma, including its subsidiaries, and Sun Pharma Advanced Research Company (SPARC) on Wednesday announced the signing of a licensing ...

Learn everything you need to know about Phenobarbital-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

New Delhi, Jan 25 (PTI) Sun Pharmaceutical Industries Ltd on Wednesday launched its phenobarbital sodium injection, SEZABY for treatment of neonatal seizures in the US. New Delhi, Jan 25 (PTI) Sun ...

Sun Pharmaceutical Industries Limited has announced the launch of SEZABY, a phenobarbital sodium injection in the U.S. for the treatment of neonatal seizures. According to the statement, SEZABY is the ...

Sun Pharmaceutical Industries Ltd on Wednesday launched its phenobarbital sodium injection, SEZABY for treatment of neonatal seizures in the US. SEZABY is the first and only product approved by the US ...